{{Rsnum
|rsid=805304
|Gene=CLIC1
|Chromosome=6
|position=31730311
|Orientation=minus
|GMAF=0.4738
|Gene_s=CLIC1,DDAH2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 53.1 | 38.9 | 8.0
| HCB | 30.7 | 50.4 | 19.0
| JPT | 32.7 | 45.1 | 22.1
| YRI | 4.2 | 16.7 | 79.2
| ASW | 7.0 | 40.4 | 52.6
| CHB | 30.7 | 50.4 | 19.0
| CHD | 33.9 | 48.6 | 17.4
| GIH | 31.7 | 53.5 | 14.9
| LWK | 13.6 | 35.5 | 50.9
| MEX | 31.0 | 53.4 | 15.5
| MKK | 10.3 | 44.5 | 45.2
| TSI | 39.2 | 46.1 | 14.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=19666123
|Title=Polymorphisms in the promoter region of the dimethylarginine dimethylaminohydrolase 2 gene are associated with prevalence of hypertension
}}

{{PMID|20805886|OA=1
}} Unique DNA repair gene variations and potential associations with the primary antibody deficiency syndromes IgAD and CVID.

{{PMID|22579530}} Association of the DDAH2 gene polymorphism with type 2 diabetes and hypertension.

{{PMID Auto
|PMID=23129820
|Title=Chronic renal impairment and DDAH2-1151 A/C polymorphism determine ADMA levels in type 2 diabetic subjects
}}

{{PMID Auto
|PMID=23147199
|Title=ADMA, SDMA and L-arginine/ADMA Ratio but not DDAH Genetic Polymorphisms are Reliable Predictors of Diabetic Nephropathy Progression as Identified by Competing Risk Analysis
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}